Data as of Jul 29
| +0.02 / +6.25%|
The 1 analysts offering 12-month price forecasts for Remedent Inc have a median target of 1.50, with a high estimate of 1.50 and a low estimate of 1.50. The median estimate represents a +341.18% increase from the last price of 0.34.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.